If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.109.No.12 page 1" href="http://viewer.zmags.com/publication/38b07167?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.amj</a> <a title="AJG_Vol.109.No.12 page 2" href="http://viewer.zmags.com/publication/38b07167?page=2"> VOLUME 109 NUMBER 12 DECEMBER 2014 www.amjgastro.</a> <a title="AJG_Vol.109.No.12 page 3" href="http://viewer.zmags.com/publication/38b07167?page=3"> InActive,MildtoModerateUlcerativeColitis(UC) POWE</a> <a title="AJG_Vol.109.No.12 page 4" href="http://viewer.zmags.com/publication/38b07167?page=4"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.109.No.12 page 5" href="http://viewer.zmags.com/publication/38b07167?page=5"> </a> <a title="AJG_Vol.109.No.12 page 6" href="http://viewer.zmags.com/publication/38b07167?page=6"> A NEW FACE IN HCV abbviehcv.com </a> <a title="AJG_Vol.109.No.12 page 7" href="http://viewer.zmags.com/publication/38b07167?page=7"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.109.No.12 page 8" href="http://viewer.zmags.com/publication/38b07167?page=8"> A NEW NAME. A LEGACY OF INGENUITY. THE METHODIST </a> <a title="AJG_Vol.109.No.12 page 9" href="http://viewer.zmags.com/publication/38b07167?page=9"> Urgent Request for Manuscripts Address</a> <a title="AJG_Vol.109.No.12 page 10" href="http://viewer.zmags.com/publication/38b07167?page=10"> </a> <a title="AJG_Vol.109.No.12 page 11" href="http://viewer.zmags.com/publication/38b07167?page=11"> </a> <a title="AJG_Vol.109.No.12 page 12" href="http://viewer.zmags.com/publication/38b07167?page=12"> FOR THE INDUCTION OF R</a> <a title="AJG_Vol.109.No.12 page 13" href="http://viewer.zmags.com/publication/38b07167?page=13"> Brief Summary UCERIS (budesonide) 2 mg rectal foa</a> <a title="AJG_Vol.109.No.12 page 14" href="http://viewer.zmags.com/publication/38b07167?page=14"> For the treatment of HCV in GT 1 patients </a> <a title="AJG_Vol.109.No.12 page 15" href="http://viewer.zmags.com/publication/38b07167?page=15"> HARVONI is a once-daily single-tablet regimen for</a> <a title="AJG_Vol.109.No.12 page 16" href="http://viewer.zmags.com/publication/38b07167?page=16"> NOW APPROVED ONE IS HERE IMPORTANT SAFETY I</a> <a title="AJG_Vol.109.No.12 page 17" href="http://viewer.zmags.com/publication/38b07167?page=17"> HARVONI® (ledipasvir 90 mg and sofosbuvir 400 mg)</a> <a title="AJG_Vol.109.No.12 page 18" href="http://viewer.zmags.com/publication/38b07167?page=18"> Brief Summary (cont.) Consider alternative HCV</a> <a title="AJG_Vol.109.No.12 page 19" href="http://viewer.zmags.com/publication/38b07167?page=19"> Ournationally ranked Gastroenterology and GI Surg</a> <a title="AJG_Vol.109.No.12 page 20" href="http://viewer.zmags.com/publication/38b07167?page=20"> OFFICIAL PUBLICATION OF THE AMERICAN COLLEGE</a> <a title="AJG_Vol.109.No.12 page 21" href="http://viewer.zmags.com/publication/38b07167?page=21"> For patients with</a> <a title="AJG_Vol.109.No.12 page 22" href="http://viewer.zmags.com/publication/38b07167?page=22"> To request samples, call 1-800-828-2845 or visit </a> <a title="AJG_Vol.109.No.12 page 23" href="http://viewer.zmags.com/publication/38b07167?page=23"> BRIEF SUMMARY: Consult the Full Prescribing Infor</a> <a title="AJG_Vol.109.No.12 page 24" href="http://viewer.zmags.com/publication/38b07167?page=24"> not always possible to reliably estimate their fr</a> <a title="AJG_Vol.109.No.12 page 25" href="http://viewer.zmags.com/publication/38b07167?page=25"> IMPORTANT SAFETY INFORMATION SERIOUS INFECTIONS P</a> <a title="AJG_Vol.109.No.12 page 26" href="http://viewer.zmags.com/publication/38b07167?page=26"> GET SERIOUS WITH REMICADE® (infIiximab) She may </a> <a title="AJG_Vol.109.No.12 page 27" href="http://viewer.zmags.com/publication/38b07167?page=27"> IMPORTANT SAFETY INFORMATION (CONTINUED) MALIGNAN</a> <a title="AJG_Vol.109.No.12 page 28" href="http://viewer.zmags.com/publication/38b07167?page=28"> REMICADE (infliximab) Lyophilized Concentrate for</a> <a title="AJG_Vol.109.No.12 page 29" href="http://viewer.zmags.com/publication/38b07167?page=29"> REMICADE® (infliximab) disease, psoriatic arthr</a> <a title="AJG_Vol.109.No.12 page 30" href="http://viewer.zmags.com/publication/38b07167?page=30"> REMICADE® (infliximab) REMICADE infusions, 3% w</a> <a title="AJG_Vol.109.No.12 page 31" href="http://viewer.zmags.com/publication/38b07167?page=31"> REMICADE® (infliximab) Adverse Reactions in Pso</a> <a title="AJG_Vol.109.No.12 page 32" href="http://viewer.zmags.com/publication/38b07167?page=32"> REMICADE® (infliximab) REMICADE during or withi</a> <a title="AJG_Vol.109.No.12 page 33" href="http://viewer.zmags.com/publication/38b07167?page=33"> Whether it's running to a sales call, or running </a> <a title="AJG_Vol.109.No.12 page 34" href="http://viewer.zmags.com/publication/38b07167?page=34"> The CCFA's motto of “Providing hope and inspiring</a> <a title="AJG_Vol.109.No.12 page 35" href="http://viewer.zmags.com/publication/38b07167?page=35"> ĆĒĊėĎĈĆēĈĔđđĊČĊĔċČĆĘęėĔĊēęĊėĔđĔČĞ ACG2015 Hawa</a> <a title="AJG_Vol.109.No.12 page 36" href="http://viewer.zmags.com/publication/38b07167?page=36"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.109.No.12 page 37" href="http://viewer.zmags.com/publication/38b07167?page=37"> CRANBERRY FLAVOR AVAILABLE JANUARY 2015! </a> <a title="AJG_Vol.109.No.12 page 38" href="http://viewer.zmags.com/publication/38b07167?page=38"> A massively dilated esophagus with abrupt narrowi</a> <a title="AJG_Vol.109.No.12 page 39" href="http://viewer.zmags.com/publication/38b07167?page=39"> CONTENTS </a> <a title="AJG_Vol.109.No.12 page 40" href="http://viewer.zmags.com/publication/38b07167?page=40"> PartnerPublishing Superior Science T</a> <a title="AJG_Vol.109.No.12 page 41" href="http://viewer.zmags.com/publication/38b07167?page=41"> For adults with genotype 1 (G1) chronic hepatitis</a> <a title="AJG_Vol.109.No.12 page 42" href="http://viewer.zmags.com/publication/38b07167?page=42"> (Data from December 6, 2013 to October 17, 2014)1</a> <a title="AJG_Vol.109.No.12 page 43" href="http://viewer.zmags.com/publication/38b07167?page=43"> OLYSIO (simeprevir) capsules, for oral use Brief </a> <a title="AJG_Vol.109.No.12 page 44" href="http://viewer.zmags.com/publication/38b07167?page=44"> OLYSIO® (simeprevir) capsules, for oral use WAR</a> <a title="AJG_Vol.109.No.12 page 45" href="http://viewer.zmags.com/publication/38b07167?page=45"> OLYSIO® (simeprevir) capsules, for oral use Lab</a> <a title="AJG_Vol.109.No.12 page 46" href="http://viewer.zmags.com/publication/38b07167?page=46"> OLYSIO® (simeprevir) capsules, for oral use Tab</a> <a title="AJG_Vol.109.No.12 page 47" href="http://viewer.zmags.com/publication/38b07167?page=47"> OLYSIO® (simeprevir) capsules, for oral use Tab</a> <a title="AJG_Vol.109.No.12 page 48" href="http://viewer.zmags.com/publication/38b07167?page=48"> OLYSIO® (simeprevir) capsules, for oral use Tab</a> <a title="AJG_Vol.109.No.12 page 49" href="http://viewer.zmags.com/publication/38b07167?page=49"> OLYSIO® (simeprevir) capsules, for oral use Liver</a> <a title="AJG_Vol.109.No.12 page 50" href="http://viewer.zmags.com/publication/38b07167?page=50"> The American College of Gastroenterology Explore</a> <a title="AJG_Vol.109.No.12 page 51" href="http://viewer.zmags.com/publication/38b07167?page=51"> Leave questions in the past. Get answers as to wh</a> <a title="AJG_Vol.109.No.12 page 52" href="http://viewer.zmags.com/publication/38b07167?page=52"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 53" href="http://viewer.zmags.com/publication/38b07167?page=53"> 1842 THE RED SECTION IBS/RD (</a> <a title="AJG_Vol.109.No.12 page 54" href="http://viewer.zmags.com/publication/38b07167?page=54"> THE RED SECTION 1843 What’s Hot in the RED J</a> <a title="AJG_Vol.109.No.12 page 55" href="http://viewer.zmags.com/publication/38b07167?page=55"> 1844 THE RED SECTION </a> <a title="AJG_Vol.109.No.12 page 56" href="http://viewer.zmags.com/publication/38b07167?page=56"> Variation in medical record documentation and </a> <a title="AJG_Vol.109.No.12 page 57" href="http://viewer.zmags.com/publication/38b07167?page=57"> 1846 THE RED SECTION Table 1. Patient demog</a> <a title="AJG_Vol.109.No.12 page 58" href="http://viewer.zmags.com/publication/38b07167?page=58"> THE RED SECTION 1847 Table 2. Patient age, c</a> <a title="AJG_Vol.109.No.12 page 59" href="http://viewer.zmags.com/publication/38b07167?page=59"> 0.0% 10.0% 20.0% 30.0% </a> <a title="AJG_Vol.109.No.12 page 60" href="http://viewer.zmags.com/publication/38b07167?page=60"> sensitivity analysis varying the cutoff for the r</a> <a title="AJG_Vol.109.No.12 page 61" href="http://viewer.zmags.com/publication/38b07167?page=61"> 1850 THE RED SECTION </a> <a title="AJG_Vol.109.No.12 page 62" href="http://viewer.zmags.com/publication/38b07167?page=62"> as to target adherence-improvement interventions.</a> <a title="AJG_Vol.109.No.12 page 63" href="http://viewer.zmags.com/publication/38b07167?page=63"> 1852 THE RED SECTION Survey testing and va</a> <a title="AJG_Vol.109.No.12 page 64" href="http://viewer.zmags.com/publication/38b07167?page=64"> Table 2. Correlation (Spearman, ρ) between MMAS-8</a> <a title="AJG_Vol.109.No.12 page 65" href="http://viewer.zmags.com/publication/38b07167?page=65"> 1854 THE RED SECTION Table 3. Correlation (</a> <a title="AJG_Vol.109.No.12 page 66" href="http://viewer.zmags.com/publication/38b07167?page=66"> and follow-up and Drs Kenneth Falchuk, Jacqueline</a> <a title="AJG_Vol.109.No.12 page 67" href="http://viewer.zmags.com/publication/38b07167?page=67"> 1856 THE RED SECTION </a> <a title="AJG_Vol.109.No.12 page 68" href="http://viewer.zmags.com/publication/38b07167?page=68"> Table 1. Examples of Food and Drug Administration</a> <a title="AJG_Vol.109.No.12 page 69" href="http://viewer.zmags.com/publication/38b07167?page=69"> 1858 THE RED SECTION </a> <a title="AJG_Vol.109.No.12 page 70" href="http://viewer.zmags.com/publication/38b07167?page=70"> ACKNOWLEDGMENTS The following members of the Amer</a> <a title="AJG_Vol.109.No.12 page 71" href="http://viewer.zmags.com/publication/38b07167?page=71"> 1860 THE RED SECTION </a> <a title="AJG_Vol.109.No.12 page 72" href="http://viewer.zmags.com/publication/38b07167?page=72"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 73" href="http://viewer.zmags.com/publication/38b07167?page=73"> 1862 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 74" href="http://viewer.zmags.com/publication/38b07167?page=74"> United States. Furthermore, none of these studies</a> <a title="AJG_Vol.109.No.12 page 75" href="http://viewer.zmags.com/publication/38b07167?page=75"> 1864 Shakhatreh et al. ESOPHAGUS Statistica</a> <a title="AJG_Vol.109.No.12 page 76" href="http://viewer.zmags.com/publication/38b07167?page=76"> Table 2. Incidence rates of esophageal adenocarci</a> <a title="AJG_Vol.109.No.12 page 77" href="http://viewer.zmags.com/publication/38b07167?page=77"> 1866 Shakhatreh et al. Cumulative incidence </a> <a title="AJG_Vol.109.No.12 page 78" href="http://viewer.zmags.com/publication/38b07167?page=78"> Table 3. Incidence rates of esophageal adenocarci</a> <a title="AJG_Vol.109.No.12 page 79" href="http://viewer.zmags.com/publication/38b07167?page=79"> 1868 Shakhatreh et al. ESOPHAGUS with esoph</a> <a title="AJG_Vol.109.No.12 page 80" href="http://viewer.zmags.com/publication/38b07167?page=80"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 81" href="http://viewer.zmags.com/publication/38b07167?page=81"> 1870 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 82" href="http://viewer.zmags.com/publication/38b07167?page=82"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 83" href="http://viewer.zmags.com/publication/38b07167?page=83"> 1872 Nguyen et al. ESOPHAGUS Statistical an</a> <a title="AJG_Vol.109.No.12 page 84" href="http://viewer.zmags.com/publication/38b07167?page=84"> Risk Factors for BE 1873 P value </a> <a title="AJG_Vol.109.No.12 page 85" href="http://viewer.zmags.com/publication/38b07167?page=85"> 1874 Nguyen et al. P value P value (all </a> <a title="AJG_Vol.109.No.12 page 86" href="http://viewer.zmags.com/publication/38b07167?page=86"> Risk Factors for BE 1875 P value P value </a> <a title="AJG_Vol.109.No.12 page 87" href="http://viewer.zmags.com/publication/38b07167?page=87"> 1876 Nguyen et al. ESOPHAGUS Table 3. Univa</a> <a title="AJG_Vol.109.No.12 page 88" href="http://viewer.zmags.com/publication/38b07167?page=88"> Table 4. Characteristics of BE among NHW and AA c</a> <a title="AJG_Vol.109.No.12 page 89" href="http://viewer.zmags.com/publication/38b07167?page=89"> 1878 Nguyen et al. ESOPHAGUS Table 5. Univa</a> <a title="AJG_Vol.109.No.12 page 90" href="http://viewer.zmags.com/publication/38b07167?page=90"> factor profile for BE differed racially, as high </a> <a title="AJG_Vol.109.No.12 page 91" href="http://viewer.zmags.com/publication/38b07167?page=91"> 1880 Nguyen et al. ESOPHAGUS 26. Fischbach </a> <a title="AJG_Vol.109.No.12 page 92" href="http://viewer.zmags.com/publication/38b07167?page=92"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 93" href="http://viewer.zmags.com/publication/38b07167?page=93"> 1882 Chaiteerakij et al. LIVER are limited,</a> <a title="AJG_Vol.109.No.12 page 94" href="http://viewer.zmags.com/publication/38b07167?page=94"> A total of 413 pCCA patients were included in t</a> <a title="AJG_Vol.109.No.12 page 95" href="http://viewer.zmags.com/publication/38b07167?page=95"> 1884 Chaiteerakij et al. LIVER Table 1. Bas</a> <a title="AJG_Vol.109.No.12 page 96" href="http://viewer.zmags.com/publication/38b07167?page=96"> Staging System for Perihilar Cholangiocarcinoma </a> <a title="AJG_Vol.109.No.12 page 97" href="http://viewer.zmags.com/publication/38b07167?page=97"> 1886 Chaiteerakij et al. LIVER The entire c</a> <a title="AJG_Vol.109.No.12 page 98" href="http://viewer.zmags.com/publication/38b07167?page=98"> Staging System for Perihilar Cholangiocarcinoma </a> <a title="AJG_Vol.109.No.12 page 99" href="http://viewer.zmags.com/publication/38b07167?page=99"> 1888 Chaiteerakij et al. LIVER including tu</a> <a title="AJG_Vol.109.No.12 page 100" href="http://viewer.zmags.com/publication/38b07167?page=100"> instead of the classical pathologic TNM staging a</a> <a title="AJG_Vol.109.No.12 page 101" href="http://viewer.zmags.com/publication/38b07167?page=101"> 1890 Chaiteerakij et al. LIVER 19. Heimbach</a> <a title="AJG_Vol.109.No.12 page 102" href="http://viewer.zmags.com/publication/38b07167?page=102"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 103" href="http://viewer.zmags.com/publication/38b07167?page=103"> 1892 Feng et al. LIVER invasive option to e</a> <a title="AJG_Vol.109.No.12 page 104" href="http://viewer.zmags.com/publication/38b07167?page=104"> or at the periphery of the ablated zone. The RFA </a> <a title="AJG_Vol.109.No.12 page 105" href="http://viewer.zmags.com/publication/38b07167?page=105"> 1894 Feng et al. LIVER Table 1. Baseline pa</a> <a title="AJG_Vol.109.No.12 page 106" href="http://viewer.zmags.com/publication/38b07167?page=106"> Sorafenib–Radiofrequency Ablation in BCLC 0–B1 HC</a> <a title="AJG_Vol.109.No.12 page 107" href="http://viewer.zmags.com/publication/38b07167?page=107"> 1896 Feng et al. 1 </a> <a title="AJG_Vol.109.No.12 page 108" href="http://viewer.zmags.com/publication/38b07167?page=108"> Sorafenib–Radiofrequency Ablation in BCLC 0–B1 HC</a> <a title="AJG_Vol.109.No.12 page 109" href="http://viewer.zmags.com/publication/38b07167?page=109"> 1898 Feng et al. LIVER Sorafenib–RFA in Jap</a> <a title="AJG_Vol.109.No.12 page 110" href="http://viewer.zmags.com/publication/38b07167?page=110"> 17. Zhao Y, Wang WJ, Guan S et al. Sorafenib comb</a> <a title="AJG_Vol.109.No.12 page 111" href="http://viewer.zmags.com/publication/38b07167?page=111"> 1900 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 112" href="http://viewer.zmags.com/publication/38b07167?page=112"> functional bowel disorders. These studies showed </a> <a title="AJG_Vol.109.No.12 page 113" href="http://viewer.zmags.com/publication/38b07167?page=113"> 1902 Yamada et al. Consecutive patients un</a> <a title="AJG_Vol.109.No.12 page 114" href="http://viewer.zmags.com/publication/38b07167?page=114"> Table 2. Comparison of the IBS group and non-IBS </a> <a title="AJG_Vol.109.No.12 page 115" href="http://viewer.zmags.com/publication/38b07167?page=115"> 1904 Yamada et al. GI DISORDERS FUNCTIONAL </a> <a title="AJG_Vol.109.No.12 page 116" href="http://viewer.zmags.com/publication/38b07167?page=116"> 11. Yamada E, Ohkubo H, Higurashi T et al. Viscer</a> <a title="AJG_Vol.109.No.12 page 117" href="http://viewer.zmags.com/publication/38b07167?page=117"> 1906 EDITORIAL </a> <a title="AJG_Vol.109.No.12 page 118" href="http://viewer.zmags.com/publication/38b07167?page=118"> ascertain the time sequence of events and hence t</a> <a title="AJG_Vol.109.No.12 page 119" href="http://viewer.zmags.com/publication/38b07167?page=119"> 1908 Spiller refine this model and identi</a> <a title="AJG_Vol.109.No.12 page 120" href="http://viewer.zmags.com/publication/38b07167?page=120"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 121" href="http://viewer.zmags.com/publication/38b07167?page=121"> 1910 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 122" href="http://viewer.zmags.com/publication/38b07167?page=122"> was uncontrolled, suggest that duodenal lipid inf</a> <a title="AJG_Vol.109.No.12 page 123" href="http://viewer.zmags.com/publication/38b07167?page=123"> 1912 Bharucha et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.12 page 124" href="http://viewer.zmags.com/publication/38b07167?page=124"> Glycemia and enteral hormonal measurements Blood </a> <a title="AJG_Vol.109.No.12 page 125" href="http://viewer.zmags.com/publication/38b07167?page=125"> Carbohydrate infusion 1914 Bharucha et al. </a> <a title="AJG_Vol.109.No.12 page 126" href="http://viewer.zmags.com/publication/38b07167?page=126"> Enteral Chemosensitivity in Functional Dyspepsia </a> <a title="AJG_Vol.109.No.12 page 127" href="http://viewer.zmags.com/publication/38b07167?page=127"> 1916 Bharucha et al. </a> <a title="AJG_Vol.109.No.12 page 128" href="http://viewer.zmags.com/publication/38b07167?page=128"> Enteral Chemosensitivity in Functional Dyspepsia </a> <a title="AJG_Vol.109.No.12 page 129" href="http://viewer.zmags.com/publication/38b07167?page=129"> 1918 Bharucha et al. predictor of the mea</a> <a title="AJG_Vol.109.No.12 page 130" href="http://viewer.zmags.com/publication/38b07167?page=130"> responsiveness to GLP1 might explain impaired gas</a> <a title="AJG_Vol.109.No.12 page 131" href="http://viewer.zmags.com/publication/38b07167?page=131"> 1920 Bharucha et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.12 page 132" href="http://viewer.zmags.com/publication/38b07167?page=132"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 133" href="http://viewer.zmags.com/publication/38b07167?page=133"> 1922 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 134" href="http://viewer.zmags.com/publication/38b07167?page=134"> Epidemiology of GCHPs and MVHPs 1923 COLON/SM</a> <a title="AJG_Vol.109.No.12 page 135" href="http://viewer.zmags.com/publication/38b07167?page=135"> 1924 Qazi et al. BRAF serrated polyp pat</a> <a title="AJG_Vol.109.No.12 page 136" href="http://viewer.zmags.com/publication/38b07167?page=136"> depth of scope insertion, and quality of bowel pr</a> <a title="AJG_Vol.109.No.12 page 137" href="http://viewer.zmags.com/publication/38b07167?page=137"> 1926 Qazi et al. COLON/SMALL BOWEL Table 3.</a> <a title="AJG_Vol.109.No.12 page 138" href="http://viewer.zmags.com/publication/38b07167?page=138"> Epidemiology of GCHPs and MVHPs 1927 Table </a> <a title="AJG_Vol.109.No.12 page 139" href="http://viewer.zmags.com/publication/38b07167?page=139"> 1928 Qazi et al. COLON/SMALL BOWEL Table 4.</a> <a title="AJG_Vol.109.No.12 page 140" href="http://viewer.zmags.com/publication/38b07167?page=140"> Epidemiology of GCHPs and MVHPs 1929 Table </a> <a title="AJG_Vol.109.No.12 page 141" href="http://viewer.zmags.com/publication/38b07167?page=141"> 1930 Qazi et al. COLON/SMALL BOWEL pathway </a> <a title="AJG_Vol.109.No.12 page 142" href="http://viewer.zmags.com/publication/38b07167?page=142"> Study Highlights WHAT IS CURRENT KNOWLEDGE ✓ The</a> <a title="AJG_Vol.109.No.12 page 143" href="http://viewer.zmags.com/publication/38b07167?page=143"> 1932 Qazi et al. COLON/SMALL BOWEL 36. DiSa</a> <a title="AJG_Vol.109.No.12 page 144" href="http://viewer.zmags.com/publication/38b07167?page=144"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 145" href="http://viewer.zmags.com/publication/38b07167?page=145"> 1934 Wacklin et al. COLON/SMALL BOWEL focus</a> <a title="AJG_Vol.109.No.12 page 146" href="http://viewer.zmags.com/publication/38b07167?page=146"> Blood hemoglobin (reference values: men 134–167 g</a> <a title="AJG_Vol.109.No.12 page 147" href="http://viewer.zmags.com/publication/38b07167?page=147"> 1936 Wacklin et al. COLON/SMALL BOWEL persi</a> <a title="AJG_Vol.109.No.12 page 148" href="http://viewer.zmags.com/publication/38b07167?page=148"> 0.4 0.2 0.0 PCA1 – 30.36% –0.2 –0.4 –0.</a> <a title="AJG_Vol.109.No.12 page 149" href="http://viewer.zmags.com/publication/38b07167?page=149"> 1938 Wacklin et al. P =0.05 50 40 </a> <a title="AJG_Vol.109.No.12 page 150" href="http://viewer.zmags.com/publication/38b07167?page=150"> we have recently shown that delayed diagnosis is </a> <a title="AJG_Vol.109.No.12 page 151" href="http://viewer.zmags.com/publication/38b07167?page=151"> 1940 Wacklin et al. COLON/SMALL BOWEL intri</a> <a title="AJG_Vol.109.No.12 page 152" href="http://viewer.zmags.com/publication/38b07167?page=152"> 16. Viljamaa M, Collin P, Huhtala H et al. Is coe</a> <a title="AJG_Vol.109.No.12 page 153" href="http://viewer.zmags.com/publication/38b07167?page=153"> 1942 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.12 page 154" href="http://viewer.zmags.com/publication/38b07167?page=154"> would greatly affect patient management. In addit</a> <a title="AJG_Vol.109.No.12 page 155" href="http://viewer.zmags.com/publication/38b07167?page=155"> 1944 Cote et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.109.No.12 page 156" href="http://viewer.zmags.com/publication/38b07167?page=156"> Diagnostic Test for PDAC Using miRNAs as Biomarke</a> <a title="AJG_Vol.109.No.12 page 157" href="http://viewer.zmags.com/publication/38b07167?page=157"> 1946 Cote et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.109.No.12 page 158" href="http://viewer.zmags.com/publication/38b07167?page=158"> Diagnostic Test for PDAC Using miRNAs as Biomarke</a> <a title="AJG_Vol.109.No.12 page 159" href="http://viewer.zmags.com/publication/38b07167?page=159"> miR-106b 50 10 Median 8.4 1.4 0.9 </a> <a title="AJG_Vol.109.No.12 page 160" href="http://viewer.zmags.com/publication/38b07167?page=160"> Diagnostic Test for PDAC Using miRNAs as Biomarke</a> <a title="AJG_Vol.109.No.12 page 161" href="http://viewer.zmags.com/publication/38b07167?page=161"> 1950 Cote et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.109.No.12 page 162" href="http://viewer.zmags.com/publication/38b07167?page=162"> with CP, an at-risk population who may be conside</a> <a title="AJG_Vol.109.No.12 page 163" href="http://viewer.zmags.com/publication/38b07167?page=163"> 1952 Cote et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.109.No.12 page 164" href="http://viewer.zmags.com/publication/38b07167?page=164"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 165" href="http://viewer.zmags.com/publication/38b07167?page=165"> 1954 Letters to the Editor </a> <a title="AJG_Vol.109.No.12 page 166" href="http://viewer.zmags.com/publication/38b07167?page=166"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 167" href="http://viewer.zmags.com/publication/38b07167?page=167"> 1956 Letters to the Editor </a> <a title="AJG_Vol.109.No.12 page 168" href="http://viewer.zmags.com/publication/38b07167?page=168"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 169" href="http://viewer.zmags.com/publication/38b07167?page=169"> 1958 Letters to the Editor </a> <a title="AJG_Vol.109.No.12 page 170" href="http://viewer.zmags.com/publication/38b07167?page=170"> nature publishing group </a> <a title="AJG_Vol.109.No.12 page 171" href="http://viewer.zmags.com/publication/38b07167?page=171"> 1960 ANNOUNCEMENTS </a> <a title="AJG_Vol.109.No.12 page 172" href="http://viewer.zmags.com/publication/38b07167?page=172"> CLASSIFIEDS www.naturejobs.com Please get in </a> <a title="AJG_Vol.109.No.12 page 173" href="http://viewer.zmags.com/publication/38b07167?page=173"> Gastroenterology Call This Top 10 “Best Places to</a> <a title="AJG_Vol.109.No.12 page 174" href="http://viewer.zmags.com/publication/38b07167?page=174"> Gastroenterologists Needed in Salt Lake City & St</a> <a title="AJG_Vol.109.No.12 page 175" href="http://viewer.zmags.com/publication/38b07167?page=175"> Gastroenterologist Baltimore, Maryland Baltimore</a> <a title="AJG_Vol.109.No.12 page 176" href="http://viewer.zmags.com/publication/38b07167?page=176"> ScopeGuide Real-time, 3D visualization of the sco</a> <a title="AJG_Vol.109.No.12 page 177" href="http://viewer.zmags.com/publication/38b07167?page=177"> Adding painless, non-surgical hemorrhoid </a>